IA
ONCE

IFP Advisors’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

IFP Advisors’s Portfolio ONCE Stock Details ONCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-200
Closed -$18K – 4257
2017
Q3 		$18K Buy
+200
New +$15.2K ﹤0.01% 2685

Other funds holding ONCE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

IFP Advisors's ONCE Position: Q1 2019 in Review

IFP Advisors sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q1 2019, closing a stake of 825 shares — an estimated $32K sold.

IFP Advisors first reported a position in ONCE in Q4 2015 and held it in 12 quarters. The position peaked at $192K in Q3 2017. 199 funds tracked by Wall St. Rank hold ONCE as of Q1 2019.

  • IFP Advisors reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • IFP Advisors sold 825 Spark Therapeutics, Inc. Common Stock shares in Q1 2019, an estimated $32K.
  • IFP Advisors first reported a position in Spark Therapeutics, Inc. Common Stock in Q4 2015 and held it in 12 quarters.
  • IFP Advisors's Spark Therapeutics, Inc. Common Stock position peaked at $192K in Q3 2017.
  • 199 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q1 2019.

Based on IFP Advisors's 13F filing for Q1 2019, filed 15 May 2019.